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Abstract
Background: Galactofuranose is an essential cell surface component present in bacteria, fungi and several
nematodes such as Caenorhabditis spp., Brugia spp., Onchocerca spp. and Strongyloides spp. This sugar maintains the
integrity of parasite surface and is essential for virulence. UDP-Galactopyranose mutase (bmugm) plays a key role in
Galf biosynthesis by catalyzing conversion of UDP-Galactopyranose into UDP-galactofuranose and knockout studies
of the gene in Leishmania major, Mycobacterium and Aspergillus fumigatus displayed attenuated virulence while RNA
interference study in C. elegans exhibited detrimental effects. Presence of UGM in several prokaryotic and eukaryotic
microbial pathogens and its absence in higher eukaryotes renders it an attractive drug target. In the present study,
RNA interference studies have been carried out to validate bmugm as an antifilarial drug target.
Methods: RNA interference studies using two different sequences of siRNAs targeting bmugm were carried out.
The in vitro gene silencing of adult B. malayi parasites was undertaken to observe the effects on parasites. Infective
larvae were also exposed to siRNAs and their in vivo development in jirds was observed.
Results: The in vitro gene silencing induced by siRNA1 and 2 individually as well as together knocked down the
bmugm gene expression causing impaired viability of the exposed worms along with extremely reduced motility,
abridged microfilarial release and adversely effected embryogenesis. The combinatorial in vitro gene silencing
revealed marginally better results than both the siRNAs individually. Thus, infective larvae were treated with siRNA
combination which showed downregulation of bmugm mRNA expression resulting into sluggish larval movements
and/or death. The siRNA-treated actively motile larvae when inoculated intraperitoneally into jirds demonstrated
highly reduced transformation of these larvae into adult worms with detrimental effects on embryogenesis. The
effects of gene silencing were long-lasting as the adult worms developed from siRNA-treated larvae showed
noticeable knockdown in the target gene expression.
Conclusions: The validation studies undertaken here conclude that bmugm is essential for the proper development
and survival of the parasite and support its candidature as an antifilarial drug target.
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Background
Lymphatic filariasis (LF) is a vector-borne, painful and
disfiguring parasitic disease caused by Wuchereria ban-
crofti, Brugia malayi and Brugia timori, leading to severe
socio-economic consequences. Around 1.23 billion
inhabitants in 58 countries are at risk of acquiring
infection and therefore urgently require large scale pre-
ventive measures [1]. The current standard drugs iver-
mectin and diethylcarbamazine in combination with
albendazole are largely microfilaricidal, moreover they
need to be administered in a single dose, annually for
several years for proper interruption of the microfilarial
transmission. The development of resistance against
albendazole and ivermectin has been well established
[2], which highlights the urgent need of excavating
novel drug targets to discover adulticidal/embryostatic/
microfilaricidal agents. The reverse genetic approach
may be of help in this regard and RNA interference
(RNAi) provides a valuable modern drug discovery plat-
form for identifying gene(s) playing vital role in parasite
metabolism by inhibiting/silencing their expression.
Galactofuranose (Galf ), a five member ring form of
galactose, is an essential component of cell wall, cell sur-
face glycolipids and glycoproteins. It is widely distributed
among several nematodes such as the free-living Caenor-
habditis elegans and parasitic Brugia spp., Onchocerca
spp. and Strongyloides spp., as well as protozoans and
prokaryotes [3]. In mammals, this sugar is exclusively
found in hexopyranosyl form (Galp). The ubiquitous
presence of Galf in non-mammalian species is remark-
able and its expression in many pathogens suggests that
it may be an essential element for survival. Absence of
Galf in these organisms often results in morphological
abnormalities and an impaired cell wall function. Galf-
deficient mutants have been found to be hypersensitive
to drugs, exhibited constitutive osmotic stress phenotype
or had an attenuated virulence [4]. Thus, apart from
maintaining the parasite surface integrity, Galf also
appears to be essential for their virulence. Galf-biosyn-
thetic pathways have attracted quite a lot of interest as
targets for drug development against microbial infec-
tions. The flavoenzyme, UDP-Galactopyranose mutase
(UGM) plays a key role in Galf biosynthetic pathway by
catalyzing the conversion of UDP-Galactopyranose
(UDP-Galp) into UDP-galactofuranose (UDP-Galf ) [5].
Eukaryotic UGMs share nearly 25–30% similarity with
bacterial UGM and most of the substrate or FAD binding
residues have remained conserved [6]. UGM knockouts of
Leishmania major and mutants of Aspergillus fumigatus
displayed decreased/attenuated virulence [7, 8] while C.
elegans mutants exhibited larval lethality and severe em-
bryonic phenotypic deformities indicative of defective
surface coat synthesis [9]. Genome-wide RNAi screens in
C. elegans suggested that downregulation of glf-1 gene (an
orthologue of B. malayi UGM) is detrimental [10–14].
Presence of UGM in several prokaryotic and eukaryotic
microbial pathogens and its absence in higher eukaryotes
renders it an attractive drug target. An in silico study has
also confirmed its relevance as a candidate antifilarial drug
target [15]. Thus, in the present study, in vitro and in vivo
validation of B. malayi UGM as putative antifilarial drug
target has been carried out by siRNA mediated gene silen-
cing to understand the biological function of the enzyme
in human lymphatic filarial parasite, B. malayi.
Methods
Customized synthesis of siRNA
siRNAs (small interfering ribonucleic acids) were cus-
tom synthesized by Dharmacon (USA) to target B.
malayi UGM (bmugm) (NCBI: FJ860969.1). Two
sequences of siRNAs labeled with FAM (6-carboxyfluo-
rescein) showing highest specificity ranking were pro-
cured in the lyophilized form. Stock solutions (100 μM)
were prepared and stored at -80 °C.
Custom synthesized stable scrambled siRNA sequence
(negative control) tagged with FAM not bearing any se-
quence similarities with that of human, rat or mouse
and not targeting any gene of B. malayi was used to ob-
serve off target effects, if any. This scrambled siRNA was
prior tested in cell based screening where it showed no
effect on cell viability, morphology or proliferation. All
the siRNAs were sistable which means that they were
modified for nuclease resistance to enhance their stabil-
ity even in nuclease-rich environments. Sequences of
target based and scrambled siRNAs are given in Table 1.
Parasite isolation from infected jirds
Adult B. malayi parasites were recovered from jirds
(Meriones unguiculatus) within 3–5 months of intraperi-
toneal inoculation of infective larvae (L3) of B. malayi.
L3 were recovered from infected Aedes aegypti mosqui-
tοes washed in culture medium repeatedly as described
earlier [16]. The worms were retrieved by washing the
peritoneal cavity of jird. The recovered worms were
washed in culture medium RPMI-1640 containing
2 mM L-glutamine, 25 mM HEPES, 100 U/ml penicillin,
100 mg/ml streptomycin and 2.5 mg/ml amphοtericin B.
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Worms were placed in a 48-well plate keeping 1 wοrm
in 1 ml of culture medium per well and plate was kept
at 37 °C under 5% CO2 for at least 2 h to select undam-
aged, healthy and highly motile worms (male and
female) for siRNA treatment.
In vitro siRNA treatment of worms by soaking method
The healthy male and female adult worms were used
for in vitro gene silencing studies by soaking methοd as
described earlier with some modifications [17]. Five
male and five female adult worms were placed in Midi
GeBaflex tubes with molecular weight cut off (MWCO)
of 6–8 kDa (GeBa, Israel) containing 800 μl οf culture
medium fortified with 8 U RNase OUT, 1 mM spermi-
dine and 5 μM of target siRNA. The effective concen-
tration of siRNA has been optimized earlier in our lab
targeted against other B. malayi genes [17, 18]. The
tubes with scrambled siRNA and no siRNA instead of
target siRNA served as their respective negative and
medium controls. FAM labelled stable siRNAs siRNA1
and siRNA2 targeting bmugm mRNA were used alone
as well as in combination for analyzing their effect on
worms at different time points. Five tubes (medium +
worms) were kept in a 250 ml capacity screw capped
glass bottle (Schott) containing 200 ml of RPMI
medium preheated to 37 °C and enough care was taken
in order to avoid any contamination, stress and damage
to the parasites. Of these five tubes, tube 1, 2, 3, 4, 5
contained siRNA1 (5 μM), siRNA2 (5 μM), siRNA1 +
siRNA2 at 2.5 μM each, scrambled siRNA (negative
control) (5 μM) and no siRNA (medium control), re-
spectively. Five such sets of bottles were prepared for
retrieving tubes at 24, 48, 72 h and the last two for
observing the post-silencing effects. Tubes from bottle
1 were retrieved after 24 h of incubation and adult
worms were transferred to fresh medium in separate
petridishes. The medium left (800 μl) in these five tubes
was transferred to separate eppendorfs, centrifuged at
800 × g for 2 min to pellet microfilariae (mf) released in
vitro by female worms. The mf pellets were suspended
in 50 μl fresh medium and microscopically examined at
different time points during (24, 48, 72 h), post-gene si-
lencing (96, 120 h) for enumeration. Ten microliters of
mf suspension was spread into thin smear on a glass
slide and stained with Giemsa for observing the pheno-
typic changes, if any. The images were captured by
colour digital camera (Nikon, Tokyo, Japan).
Penetration of siRNA into the treated worm was af-
firmed by visualization under the fluorescent microscope
(FLoid Cell Imaging Station; Life technologies, CA,
USA) at 520 nm emission. However, size/stage-matched
parasites were also captured for autofluorescence if any.
Two female worms and three male worms from each
tube were frozen in Trizol for nucleic acid preparation
to measure target gene mRNA expression employing
real-time quantitative RT-PCR (qRT-PCR). Further, two
male and two female worms were transferred to fresh
culture medium at 37 °C for 30 min to assess their mo-
tility and percentage inhibition in motility, if any. The
viability of these worms was evaluated by MTT [3-(4, 5
dimethylthiazol-2-yl)-2, 5 diphenyltetrazolium bromide]
reduction assay [19, 20]. The remaining one female was
teased and microscopically examined for intrauterine
contents to determine the effect of gene silencing on
embryogenesis and other developing progenies. Worms
kept in the tubes in two other bottles were also proc-
essed in the same way after retrieving parasites at 48 and
72 h respectively. Worms from the last two bottles were
examined for post-silencing effects beyond 72 h after
transferring treated worms to siRNA-free fresh medium
and further incubating them for another 24 and 48 h re-
spectively. These worms were examined for motility, via-
bility and intra uterine contents and remaining parasites
were frozen in Trizol for further qRT-PCR. Mf release
was also quantified as mentioned earlier. The data stated
in the present study are the mean ± standard deviation
(SD) of the three experiments (in each experiment any
siRNA type or controls were kept in duplicates for each
time point) carried out with the same number of worms
under identical conditions.
Effect on motility and viability of B. malayi adult worms
and microfilariae
The adult worms (both sexes) from each group of target
siRNA soaked, scrambled negative and medium control
were analyzed for their motility post-transfer to fresh
media. Reduction in motility was analyzed microscopic-
ally and % motility reduction was scored as follows: 5,
1–25% reduction; 4, 26–49% reduction; 3, 50–74% re-
duction; 2, 75–99% reduction; and D (dead), 100% re-
duction. MTT utilizes mitochondrial enzyme to reduce
yellow dye into blue formazon, which is solubilised in
DMSO and read spectrophotometrically in a multiplate
reader (Tecan, Infinite M-200, Mannedorf, Switzerland)
at 540 nm indicating viability of worms. Reduction in
motility and inhibition in MTT reduction by treated
worm in comparison to those of respective controls indi-
cated the effect of gene silencing on B. malayi.
bmugm mRNA expression analysis by qRT-PCR
The downregulation in the mRNA expression levels of tar-
get specific transcript in the treated and control worms was
quantified using qRT-PCR. β-tubulin gene (Bm-tub-1) was
used as an endogenous control. The target and housekeep-
ing gene-specific primers were designed (Eurogentec,
Seraing, Belgium) for qRT-PCR (Table 2).
The treated and control worms frozen in Trizol at dif-
ferent time points (as mentioned above) were used for
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RNA extraction by Trizol method [21] followed by
DNase treatment and cDNA synthesis using Super
Script III first strand cDNA synthesis kit (Invitrogen,
CA, USA) containing oligo (dT) 20 primers. The cDNA
was amplified by qRT-PCR using the real-time PCR
primers and SYBER GREEN premix on Roche applied
System (Indianapolis, USA). PCR amplification was car-
ried out at 95 °C for 5 min, followed by 40 cycles of
95 °C for 20 s, 56 °C for 15 s, and 72 °C for 30 s using
target specific and endogenous control gene primers.
The relative fold change in mRNA expression was de-
termined by comparative ΔCT method [22].
To further support the above qRT-PCR findings a sep-
arate set of experiments were conducted to check the
changes in B. malayi UGM protein (Bm_UGM) levels in
treated and untreated worms. Polyclonal antibodies were
raised against the protein in BALB/c mice (6–8 week
old) and anti-Bm_UGM serum was collected from the
blood as mentioned earlier in [23]. The worms (3 males
+ 2 females) from each group after treatment with
medium alone and siRNAs (scrambled, siRNA1, 2, 1 + 2)
at different time points as above were homogenized,
sonicated in 300 μl PBS containing protease inhibitor
cocktail (Sigma, St Louis, Missouri, USA), protein con-
tent quantified by Bradford method and 20 μg of each
sample was resolved on 10% SDS-PAGE for Western
blotting using anti-Bm_UGM mouse serum as a primary
antibody (1:5000 dilutions). The blot was developed as
mentioned earlier [23] and percent relative intensity of
bands in comparison to medium control was quantified
by using open-source imageJ version 1.47 software (NIH,
Bethesda, MD, USA).
In vitro gene silencing in L3 and their in vivo
development in jirds
Brugia malayi L3 were kept in 48 well plate ~200 L3/
ml/well in culture medium fortified with 8 U RNase
OUT, 1 mM spermidine at 37 °C in 5% CO2 [18]. Larvae
were soaked in medium containing target siRNA1 + 2
(2 μM), scrambled siRNA (2 μM) and no siRNA
(medium control) in multiple wells for 48 h. Treated as
well as control L3 were frozen in Trizol for further
quantification of their transcript levels. After washing,
the healthy and actively motile larvae from each treated
and control groups were inoculated into the peritoneal
cavity of 6 week-old susceptible rodent host (male jird)
for examining their further in vivo development. Four
jirds were inoculated each with ~100 L3/animal recov-
ered from each group of wells. These jirds were eutha-
nized on day 120 post-larval inoculation for observing
the development of L3 into sexually mature, fertile adult
worms and presence of mf in peritoneal cavity. The live
recovered worms were measured for their length and
teased in PBS to detect defects in intrauterine develop-
ment, if any.
Statistical analysis
The in vitro and in vivo experiments were repeated three
times under similar conditions to minimize the errors, if
any. T-test (for two groups), two-way analysis of variance
(ANOVA) were used for analyzing the data. Bonferroni
method/Newman-Keuls Multiple Comparison Test was
used for making individual comparisons using PRISM
5.0 and STATISTICA 7.0 statistical software wherever
applicable. Statistical significance between experimen-
tal and control groups was evaluated as P-values ≤ 0.05,
≤ 0.01 and ≤ 0.001 which were considered to be signifi-
cant, highly significant, very highly significant and
marked as *, ** and ***, respectively. The probability of
each individual comparison was at 100 df (degrees of
freedom) for vitro real time data of adult parasites after
ANOVA while, in vivo studies (adulticidal, sterilization
and real time) the critical probability for t-test at 22 df
was used.
Results
Visualization of siRNA uptake by parasites
There was successful uptake of FAM labelled stable off
target siRNA (scrambled), siRNA1, siRNA2 and both
siRNA1 + 2 by the parasites on soaking them for 24 h
which was visible equally throughout the body of fe-
males (Fig. 1a-d), males (Fig. 2a-d), mf released by
siRNA-treated worms (Fig. 3a) and L3 (siRNA1 + 2
soaked) (Fig. 3b) till the end of exposure. The possibility
of autofluorescence was ruled out by capturing the size/
stage matched images of unexposed parasites as shown
in various figures pertaining to adult female (Fig. 1e),
adult male (Fig. 2e), mf (Fig. 3b), L3 (Fig. 3d). Phase con-
trast images are also included in each figure at right
bottom.
Impaired motility and viability of adult B. malayi
Silencing of bmugm mediated through siRNA1, siRNA2
and siRNA1 + 2 caused 50–65% inhibition in motility of
adult female and 60–70% in male wοrms within 24 h of
soaking bringing down their viability between 58 and
70%. The motility of worms decreased tremendously at
the end of 72 h (98–99%) and did not revive on transfer-
ring the treated worm to siRNA free fresh medium even
Table 2 The primers sequences used for real time RT-PCR
analysis
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up to 48 h. The worms were almost paralyzed and only
their distal end sometimes showed jerky movement on
stirring the medium. The viability and motility of treated
worms was reduced by 90–98% between 72 and 120 h
(Tables 3 and 4). These effects were more intense when
parasites were soaked in a mixture of two target siRNAs.
Reduced mf release, viability and alteration in phenotype
siRNA1, 2 and in combination significantly reduced the
release of mf from female worms in culture. The per-
cent decrease in mf density was 75 ± 2.26 (siRNA1),
73.95 ± 5.59 (siRNA2) and 79.45 ± 2.20 (siRNA1 + 2)
within 24 h which went down further to ~84–86% at
72 h and ~90% after further 48 h of transfer to siRNA-
free medium (Table 5). As expected, targeting of
bmugm by two distinct sequences specific siRNAs at
any time point proved to be marginally better. No off-
target effects were noticed in presence of scrambled
siRNA. Mf released in control cultures were healthy,
actively motile (Fig. 4a, b) unlike those targeted specif-
ically. Significant reduction (65–75%) in the motility of
released mf was observed within 24 h which was exem-
plified with increased exposure time (>90% after 48 h).
Majority of mf released at 72 h were dead (Fig. 4c-e
and Table 6) with visible phenotypic deformities
(Fig. 5a-d) as compared to intact mf from controls
(Fig. 5e).
Impaired embryogenesis in female worm
An adverse effect was also noticed on intrauterine
contents post-bmugm gene silencing in female B.
malayi. All of the stages including eggs, pretzel, ad-
vanced embryonic and microfilarial stages showed de-
generation with decrease in their proportions. Female
teased at 120 h contained 66–71% eggs, 20–23% em-
bryonic stages, 5–15% pretzel stages and merely 2–5%
mf which were much less than in control females. In
the specifically targeted worms, percentage of early
stages increased significantly with concomitant dwin-
dled counts of advanced developing stages (Fig. 6).
The eggs from the two control groups were normal
(Fig. 7a, b) as opposed to degenerated eggs in the fe-
male worms treated with siRNA1 (Fig. 7c), siRNA2
(Fig. 7d) and siRNA1 + 2 (Fig. 7e), these were either
granulated and/or shrunken (zoomed view of eggs for
showing their condition given on upper left side of
each image in Fig. 7).
Fig. 1 Successful uptake of siRNAs by female B. malayi parasites of different groups siRNA1 (a), siRNA2 (b), siRNA1 + 2 (c), scrambled siRNA
(negative control) (d), and unexposed worm with phase contrast image at right bottom (e) after 24 h. The images were taken under FLoid Cell
Imaging Station (Life technologies, US) at 520 nm emission
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Fig. 2 Successful uptake of siRNAs by male B. malayi parasites of different groups siRNA1 (a), siRNA2 (b), siRNA1 + 2 (c), scrambled siRNA
(negative control) (d) and unexposed worm with phase contrast image at right bottom (e) after 24 h under the fluorescent microscope.
The images were taken under FLoid Cell Imaging Station (Life technologies, US) at 520 nm emission
Fig. 3 Successful uptake of siRNAs by B. malayi microfilariae and infective larvae. The images show successful siRNA uptake by B. malayi
microfilariae released by siRNA-treated female parasites of different groups (a), unexposed control microfilariae (with phase contrast image at right
bottom) (b), siRNA-treated infective larvae (c), and unexposed control infective larvae (with phase contrast image at right bottom) (d) after 24 h
under the fluorescent microscope. The images were taken under FLoid Cell Imaging Station (Life technologies, US) at 520 nm emission
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Specific gene silencing led to bmugm transcript
knockdown
The statistical analysis (two way ANOVA followed by
pairwise comparisons) showed significant changes
among groups (F(3,100) = 6761, P < 0.001), at different
time points (F(4,100) = 1998, P < 0.001). Profound down-
regulation in the bmugm gene expression was noticeable
following in vitro siRNA treatment to adult B. malayi.
In female worms, mean bmugm transcript level was
cut down by approximately 113-fold (t(100) = 16.05, P <
0.001), 131-fold (t(100) = 18.67, P < 0.001) and 149-fold
(t(100) = 21.14, P < 0.001) within 24 h in presence of
siRNA1, siRNA2 and siRNA1 + 2, respectively, which
reduced further to 445-fold (t(100) = 63.51, P < 0.001), 426-
fold (t(100) = 60.72, P < 0.001) and 523-fold (t(100) = 74.54,
P < 0.001) over medium control within 72 h (Fig. 8a-f).
The transcript levels were normalized employing
housekeeping gene β-tubulin (Bm-tub-1). Male worms
also showed almost similar results as those of female
worms with marginally higher reduction in transcript
levels at 24 h [siRNA1 (204-fold, t(100) = 39.47, P <
0.001), siRNA2 (205-fold, t(100) = 39.63, P < 0.001),
siRNA1 + 2 (262-fold, t(100) = 50.75, P < 0.001] and at
72 h [siRNA1 (410-fold, t(100) = 79.42, P < 0.001),
siRNA2 (404-fold, t(100) = 78.33, P < 0.001), siRNA1 + 2
(505-fold, t(100) = 97.97, P < 0.001)] (Fig. 9a-f ).
The observations made at the protein levels of
Bm_UGM post-treatment substantiated the qRT-PCR
data. There was decline at protein levels at 24 h of treat-
ment which amplified profoundly at 72 hand remained
so up to 120 h. The graph has been plotted in terms of
band density (Additional file 1: Figure S1).
In vitro gene silencing caused L3 lethality and impaired in
vivo development
The in vitro silencing caused by siRNA1 + 2 was margin-
ally superior to each specific siRNA and therefore this
combination was used for soaking L3 to investigate the
in vitro effects followed by their further development
and establishment in the peritoneal cavity of jirds. Of
the L3 larvae soaked in siRNA1 + 2 for 24 h, 14.0% were
actively motile while majority (~76.5%) became sluggish
and a few (9.5%) died. On siRNA treatment for 48 h,
only 9.5% remained active and majority of the larvae
(~51.2%) died while 39.2% turned sluggish (Table 7) in
contrast to actively motile larvae in controls (~1–3%
slightly sluggish). There was cut down in the bmugm
transcript level of treated L3 (sluggish) by ~178-fold
over that of scrambled siRNA-treated control worms
(1.4-fold) as compared to medium control larvae control
(Fig. 10a). The actively motile L3 from cultures at the
end of 48 h treatment with target siRNAs, negative




Motility score (female worms)a % inhibition in MTT reduction (mean ± SD)
MC SCR siRNA 1 siRNA 2 siRNA 1 + 2 SCR siRNA 1 siRNA 2 siRNA 1 + 2
24 5+ 5+ 2+ 2+ 2+ 5.2 ± 0.40 66.1 ± 5.58** 57.9 ± 0.80** 58.8 ± 9.89**
48 5+ 4+ 1+ 1+ 1+ 3.7 ± 3.40 86.9 ± 1.70*** 83.4 ± 3.67*** 87.6 ± 1.9***
72 4+ 4+ 1+ 1+ 1+ 11.1 ± 1.84 87.3 ± 9.98*** 88.6 ± 1.58*** 98.1 ± 2.26***
96 4+ 4+ 1+ 1+ 1+ 11.3 ± 3.17 88.7 ± 2.47*** 91.5 ± 1.93*** 92.2 ± 2.64***
120 4+ 4+ 1+ 1+ 1+ 5.3 ± 0.83 87.8 ± 3.9*** 87.4 ± 2.8*** 90.1 ± 3.73***
Abbreviations: MC medium control; MTT (3-(4, 5 dimethylthiazol-2-yl)-2, 5 diphenyltetrazolium bromide); SCR negative control (scrambled siRNA); SD
standard deviation
**P < 0.01; ***P < 0.001
a5, 0% motility reduction; 4, 1–25% reduction; 3, 26–49% reduction; 2, 50–74% reduction; 1, 75–99% reduction; D (death), 100% reduction




Motility score (male worms)a % inhibition in MTT reduction (mean ± SD)
MC SCR siRNA 1 siRNA 2 siRNA 1 + 2 NC siRNA 1 siRNA 2 siRNA 1 + 2
24 5+ 5+ 2+ 2+ 2+ 11.6 ± 1.98 69.1 ± 9.93** 69.8 ± 2.90** 69.9 ± 2.13**
48 4+ 4+ 1+ 1+ 1+ 5.9 ± 2.95 60.7 ± 10.47** 77.2 ± 8.97*** 84.9 ± 11.95***
72 4+ 4+ 1+ 1+ 1+ 7.1 ± 3.68 80.5 ± 9.27*** 85.70 ± 8.50*** 92.7 ± 0.88***
96 3/4+ 3/4+ 1+ 1+ 1+ 6.2 ± 2.35 90.8 ± 3.60*** 87.3 ± 9.60*** 90.6 ± 9.53***
120 3/4+ 3/4+ 1+ 1+ 1+ 7.9 ± 4.13 85.2 ± 2.75*** 83.5 ± 9.85*** 90.9 ± 1.83***
Abbreviations: NC negative control (scrambled siRNA); MC medium control, MTT (3-(4, 5 dimethylthiazol-2-yl)-2, 5 diphenyltetrazolium bromide); SCR negative
control (scrambled siRNA); SD standard deviation
**P < 0.01; ***P < 0.001
a5, 0% motility reduction; 4, 1–25% reduction; 3, 26–49% reduction; 2, 50–74% reduction; 1, 75–99% reduction; D (death), 100% reduction
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control and medium control were inoculated into the
peritoneal cavity of 6 week-old male jird (4/group). Jirds
euthanized 120 days post-infection revealed drastically re-
duced (~75.3%) adult worm establishment (t-test: t(22) =
64.09, P < 0.001) (Fig. 10b, c) in addition to sterilization in
~67.3% (t-test: t(22) = 13.72, P < 0.001) of the established
live female worms demonstrating impaired embryogenesis
(Fig. 10d).
The adult worms recovered from jirds were also quan-
tified by qRT-PCR for bmugm gene expression which
revealed 68.4–73.7-fold (t-test: t(22) = 116.1 (female) and
t(22) = 88.51 (male), P < 0.001) reduced transcript levels
over control parasites (Fig. 10e, f ). No significant reduc-
tion was noticed in scrambled siRNA-treated group. The
worms recovered from jirds inoculated with target
siRNA-treated L3 were weak as compared to healthy
worms of medium control and negative control; how-
ever, there was no noticeable change in the length of
adult parasites from those of control groups (Table 8).
Table 5 Effect of siRNA treatment on microfilaria release by
female B. malayi adult parasites
Time
(h)
% inhibition in microfilaria release (mean ± SD)
SCR siRNA1 siRNA2 siRNA1 + 2
24 4.60 ± 0.85 75.4 ± 2.26*** 73.9 ± 5.59*** 79.4 ± 2.20***
48 5.3 ± 1.25 79.7 ± 1.84*** 80.0 ± 2.97*** 81.2 ± 1.96***
72 4.3 ± 0.71 85.3 ± 1.69*** 84.7 ± 2.97*** 86.3 ± 1.20***
96 3.7 ± 1.56 88.3 ± 0.99*** 87.9 ± 2.26*** 88.8 ± 1.69***
120 3.6 ± 1.56 89.5 ± 0.71*** 89.2 ± 2.26*** 90.3 ± 0.99***
Abbreviations: MC medium control; SCR negative control (scrambled siRNA); SD
standard deviation
***P < 0.001
Fig. 4 Effect of in vitro gene silencing on the microfilariae released by female B. malayi adult worm. a, b depict the healthy and motile
microfilariae of medium control (a) and negative control (scrambled siRNA) (b), dead and severely sluggish microfilariae released by siRNA1 (c),
siRNA2 (d), siRNA1 + 2-treated female parasites in vitro (e)
Table 6 Percentage reduction in motility of microfilariae
released by B. malayi female adult parasites after in vitro RNA
interference was analyzed by scoring their motility
Time
(h)
Reduction in microfilaria motilitya
MC SCR siRNA1 siRNA 2 siRNA1 + 2
24 5+ 5+ 2+ 2+ 1+
48 5+ 5+ 1+ 1+ 1+
72 5+ 5+ 1+/D 1+/D 1+/D
96 5+ 5+ 1+/D 1+/D 1+/D
120 5+ 5+ 1+/D 1+/D 1+/D
Abbreviations: MC medium control; SCR negative control (scrambled siRNA)
a5, 0% motility reduction; 4, 1–25% reduction; 3, 26–49% reduction; 2, 50–74%
reduction; 1, 75–99% reduction; D (death), 100% reduction
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Discussion
Mass drug administration is given annually in a single
dose for several years to keep microfilarial levels low to
interrupt further transmission. The suboptimal response
of filaricides together with the emergence of drug resist-
ance advocates discovery of newer chemical moieties
and novel drug targets [24–26]. The reverse genetics ap-
proach using gene silencing techniques employing small
interfering RNAs is being utilized to study gene associ-
ated disorders such as cancer, infectious, respiratory and
neurodegenerative diseases. RNAi has emerged as a
novel and potent tool that regulates post-transcriptional
Fig. 5 Phenotypic deformities observed in microfilariae. The microfilariae released by the treated B. malayi adult worms were stained with Giemsa
stain for observing the phenotype. The microfilariae recovered from the siRNA-treated groups showed slight deformities (a-d) as encircled and
marked (red) in respective images in comparison to the intact microfilariae released in control groups (e)
Fig. 6 Gene silencing effects on embryogenesis. The effect on adult female worm embryogenesis after treatment with siRNA1, 2, 1 + 2, scrambled
and medium was analyzed. The intrauterine progenies from individual female worms of treated and control groups were examined
microscopically and are expressed as the relative proportions of progeny at different stages of development. The data represent the percentage
± standard deviation (SD) of eggs, embryonic stages, pretzels and microfilariae
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gene expression and helps in functional analysis of target
gene/s in several diseases. This technique in C. elegans has
greatly helped in excavating the functionality of genes
orthologous in B. malayi. A full RNAi screen database is
available online showing the phenotypic effects caused by
silencing of genes (www.rnai.org). RNAi is being progres-
sively used for predicting potential roles of the genes in-
volved in host-parasite interactions and vital processes
essential for survival in many parasitic helminths [27]
such as Nippostrongylus brasiliensis [28], Ascaris suum
[29, 30], Haemonchus contortus [31–33], Litomosoides
sigmodontis [34], Onchocerca volvulus [35, 36], Trichos-
trongylus colubriformis [37] and Ostertagia ostertagi
[38]. Recently, an in vivo gene silencing study has been
also undertaken in B. malayi mosquito vector A.
aegypti [39]. Cathepsin-like enzymes, [40], β-tubulin
(Bm-tub-1), RNA polymerase II large subunit (Bm-
ama-1), mf sheath protein (Bm-shp-1) [41] and cysteine
proteases [42] have been functionally analyzed by soak-
ing B. malayi worms in siRNA which led to impaired
parasite survival and fecundity. Soaking method has
been found to be better in parasitic helminths and few
essential requirements need to be kept in mind before
selecting an appropriate siRNA that should include not
only sequence specificity but also most favorable
length, concentration, 3’ dinucleotide overhangs along
with low G/C content [43–46]. Studies have shown that
small size siRNAs in low concentrations are more ef-
fective and cause less off-target effects than higher con-
centrations [47, 48]. We earlier characterized and
evaluated the essentiality of few genes of B. malayi such
as ATPase RNA helicase,trehalose-6-phosphate phos-
phatase (TPP), independent phosphoglycerate mutase
(iPGM) [17, 18, 21] by RNAi using single target gene
sequence of siRNA; however, improved silencing effects
with minimal chances of off target effects could have
been obtained if more than one siRNA were used. In
the current investigation, two different siRNA se-
quences targeting same gene were employed anticipat-
ing better bmugm gene silencing, a non-B. malayi
targeted scrambled siRNA (negative control) was simul-
taneously used throughout the experiment to observe
the off target effects, if any. The siRNAs were picked
up by parasite within 24 h of soaking and were visual-
ized microscopically till the end of exposure period. In
vitro gene knockdown using siRNA1 and siRNA2 indi-
vidually as well as pooled siRNAs1 + 2 of bmugm
caused impairment in the viability of exposed worms
and tremendously reduced the parasite motility by
~98–99% within 72 h. It was interesting to observe that
adverse effects were retained even after 48 h of re-
placing the medium with fresh siRNA free medium. In
Fig. 7 Phenotypic changes observed in the eggs. After treatment of adult female B. malayi with siRNA1 (c), siRNA2 (d), siRNA1 + 2 (e) the eggs
were degenerated (shrunken) in comparison to medium control (a) and negative control (scrambled siRNA) (b). The respective zoomed images
of eggs depicting their degeneration are shown on the upper left side of each image
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addition to worm motility or viability, the release of mf
by gravid females and their motility was also abridged
up to large extent. Gene silencing had tremendous im-
pact on the embryogenesis. More and more early eggs
were visible with decrease in advanced developing
stages and degeneration of intrauterine stages suggest-
ing phenotypic deformities and development arrest.
Real time data revealed knockdown in bmugm expres-
sion which amplified further with the exposure dur-
ation and persisted even after removal of siRNA. The
pooled siRNA effects were ~100-fold more than in
presence of siRNA 1or 2 individually. Both sexes of
worms were affected in almost similar fashion. In view
of better gene silencing effects of two siRNAs, this
combination was exploited in case of infective larvae
where deleterious effects were conspicuous making
them sluggish, and/or immotile. The treated but ac-
tively motile larvae on transfer to healthy susceptible
host, jirds demonstrated their highly reduced trans-
formation in to adult worms and recovered female
worms had embryostatic effects. Although the size of
worms was within limits, they were comparatively
much thinner than those recovered from animals re-
ceiving untreated larvae. In jirds, L3 takes around 3
months to develop into sexually mature adult parasites;
however, the worms developed from siRNA-treated lar-
vae demonstrated ~2.6 times lower mRNA expression
of target gene than detected in L3s soaked for 48 h in
siRNA medium. On the contrary, gene expression in
adults established from L3 soaked in scrambled siRNA
remained unchanged. These findings suggest that
bmugm gene knockdown effect was partly reversible al-
though lasted longer even when the larvae grew and
transformed into mature adult parasites in jirds.
In C. elegans, mutation in ugm gene has been shown
to culminate in a series of phenotypic defects like trac-
tion impairment, superficial blisters, body constrictions,
larval lethality, hyper-permeability, drug sensitivity, cu-
ticle fragility and loss, depletion or masking of outer cu-
ticle components [9, 49–53] suggesing the essentiality of
Fig. 8 Knockdown in bmugm gene expression in adult B. malayi female parasites. The relative fold downregulation in mRNA expression of
bmugm in B. malayi adult female worms soaked in siRNA1, 2, 1 + 2 was quantified by real time PCR (qRT-PCR) using comparative ΔCT method at
different time interval (24, 48, 72, 96, 120 h), β-tubulin was the endogenous control housekeeping gene. The above results depict the mean ±
standard deviation (SD) derived from three separate experiments carried out under similar conditions. The gel images depicting the target
(bmugm) and endogenous control (β-tubulin) gene expression status at different time points are shown on top (a-e). ***P < 0.001 (very
highly significant)
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this gene. The current findings demonstrated impaired
adult and larval motility, viability and lethality, embryos-
tasis, and other phenotypic alterations as a result of
knockdown in bmugm gene expression.
It may therefore be inferred that bmugm is an essential
gene in lymphatic filarial parasite, B. malayi which is im-
perative for their development and survival and thus
shows its worth to be picked up as a vital gene target for
chemotherapeutic intervention.
Conclusions
The discovery of alternative chemical moieties with dif-
fering mode of action, validated antifilarial drug target
and a vaccine to combat filariasis is urgently needed.
siRNA mediated gene silencing or compound inhibitor
studies are the tools to analyze function of a gene. UGM
is widely distributed among nematodes; however, its
complete absence in mammals renders it an interesting
putative anthelmintic drug target. The drug targets in
Fig. 9 Knockdown in bmugm gene expression in adult B. malayi male parasites. The relative fold downregulation in mRNA expression of
bmugm in B. malayi adult male worms soaked in siRNA1, 2, 1 + 2 was quantified by real time PCR (qRT-PCR) using comparative ΔCT
method at different time interval (24, 48, 72, 96, 120 h), β-tubulin was the endogenous control housekeeping gene. The above results
depict the mean ± standard deviation (SD) derived from three separate experiments carried out under similar conditions. The gel images
depicting the target (bmugm) and endogenous control (β-tubulin) gene expression status at different time points are shown on top (a-e).
***P < 0.001 (very highly significant)
Table 7 Effect of siRNA treatment on infective larvae (L3) (mean number ± standard deviation)
L3
condition
MC SCR siRNA1 + 2
24 h 48 h 24 h 48 h 24 h 48 h
Active (%) 99.0 ± 0.71 96.5 ± 1.41 97.5 ± 0.27 95.7 ± 0.47 14.0 ± 0.71 9.5 ± 0.64
Sluggish (%) 1.0 ± 0.78 3.5 ± 1.42 2.5 ± 0.97 4.2 ± 1.68 76.5 ± 1.97*** 39.2 ± 3.94**
Dead (%) 0 0 0 0 9.50 ± 0.50 51.2 ± 2.83***
Abbreviations: MC medium control; SCR negative control (scrambled siRNA)
**P < 0.01; ***P < 0.001
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helminths including filariids are almost non-existent.
RNAi experiments using two B. malayi ugm-specific siR-
NAs in combination carried out in current study re-
vealed the essentiality of bmugm in filarial metabolism.
The studies were undertaken both in vitro and in vivo
which caused profound adverse effects on parasite sur-
vival and viability correlating with profound knockdown
of the target gene expression. The gene silencing effects
were long-lasting; however, partial reversal in reduced
gene expression was noticed in established adult para-
sites after 3 months of transfer of treated larvae in to
jirds. The gene knockdown was specific, no off-target ef-
fects were noticed and two specific siRNA targeting two
different prioritized gene sequences in combination
showed better gene knockdown than single siRNA. The
current findings thus validate bmugm as a potential anti-
filarial drug target. Further crystallization and docking
studies would facilitate rationale drug designing for
identifying the inhibitors against this target.
Additional file
Additional file 1: Figure S1. The graph bars depict percent relative
intensity of bands on western blot in comparison to medium control at
different time points of exposure (24, 48, 72 h) and after exposure (96,
120 h) as quantified by imageJ version 1.47 software and the blot bands
Fig. 10 Effect of in vitro gene silencing on L3 and their in vivo development in jirds. In vitro treatment of L3 with siRNA1 + 2 resulted into reduction in
bmugm gene expression and impaired their in vivo development in jirds. a siRNA treatment of L3 resulted in a significant knockdown in bmugm gene
expression after 48 h of incubation. b, c L3 incubated with siRNA1 + 2, negative siRNA and in medium for 48 h were inoculated in the peritoneal
cavity of jirds followed by euthanization on 120-day post-inoculation for recovery of adult worms which revealed significantly reduced in vivo adult
worms establishment in siRNA1 + 2 group. d Significant number of female worms recovered from siRNA-treated group displayed impaired embryogenesis.
Percent of sterile females was calculated with respect to total female worms recovered. The fold downregulation in target gene expression in
vivo recovered females (e) and males (f) was also quantified by Real time PCR. ***P < 0.001 (very highly significant)
Table 8 Effect of silencing on the length (mean ± standard
deviation) of male and female worms recovered from jirds
infected with in vitro siRNA-treated (bmugm specific, negative)
and untreated L3
Groups Worm length (cm)
Female worms Male worms
Medium control 3.7 ± 0.09 1.75 ± 0.06
Scrambled siRNA 3.7 ± 0.08 1.72 ± 0.1
siRNA1 + 2 3.5 ± 0.07** 1.58 ± 0.05*
*P < 0.05; **P < 0.01
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have been shown below each corresponding bar. Considering the
medium control intensity to be 100% at each time points the relative
intensities of treated ones have been evaluated. P-value < 0.05 was
considered significant (*), P < 0.01 as highly significant (**) and P < 0.001
as very highly significant (***). (TIF 4078 kb)
Abbreviations
Bm_UGM: B. malayi UDP-Galactopyranose mutase protein; bmugm: B. malayi
UDP-Galactopyranose mutase gene; siRNA: small interfering ribonucleic acids;
UDP-Galf: UDP-Galactofuranose; UDP-Galp: UDP-Galactopyranose
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